Heilongjiang Jiangheng Pharmaceutical

Heilongjiang Jiangheng Pharmaceutical Technology Co., Ltd. was a Chinese pharmaceutical technology company established in 2012 and based in Harbin, Heilongjiang Province. The company specialized in the research and development of traditional Chinese medicine (TCM) formulations, utilizing advanced technologies such as supercritical carbon dioxide extraction and high-energy nanotechnology to produce nano-dry paste formulations. Its patent portfolio included innovative preparation methods for various TCM products, including Yankening tablets, Pingxiao tablets, Xiao Huoluo tablets, and Yigan Jiedu capsules, targeting indications such as inflammation, cancer, arthritis, and hepatitis B. The company has since been de-registered (closed).